Lipoxin A4 and Neutrophil/Lymphocyte Ratio: A Possible Indicator in Achieved Systemic Risk Factors for Periodontitis

scientific article

Lipoxin A4 and Neutrophil/Lymphocyte Ratio: A Possible Indicator in Achieved Systemic Risk Factors for Periodontitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.12659/MSM.895115
P932PMC publication ID4551304
P698PubMed publication ID26298769
P5875ResearchGate publication ID281551991

P2093author name stringBanu Kale Köroğlu
Burak Doğan
Esra Sinem Kemer
Fatma Yeşim Kırzıoğlu
Hikmet Orhan
Oğuzhan Aksu
Özlem Fentoğlu
Süleyman Akif Çarsancaklı
P2860cites workPeriodontitis and diabetes: a two-way relationshipQ27023000
Systemic inflammation markers in patients with aggressive periodontitis: a pilot studyQ94832218
Periodontal status in subjects with hyperlipidemiaQ94847650
Obesity: preventing and managing the global epidemic. Report of a WHO consultationQ29547404
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsQ29615694
Effects of lipoxin A(4) on lipopolysaccharide induced proliferation and reactive oxygen species production in RAW264.7 macrophages through modulation of G-CSF secretionQ33293692
Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?Q33683210
Post-menopausal bone loss and its relationship to oral bone lossQ34200671
Lipoxin A4 is a novel estrogen receptor modulator.Q34212779
Gingival sulcus bleeding--a leading symptom in initial gingivitisQ34702495
Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?Q34894926
Ratio of pro-resolving and pro-inflammatory lipid mediator precursors as potential markers for aggressive periodontitisQ34947821
Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitisQ35068805
Analytical epidemiology of periodontitisQ36243411
Diabetes mellitus and periodontal diseasesQ36553573
Periodontal disease and systemic conditions: a bidirectional relationship.Q36602669
The role of reactive oxygen and antioxidant species in periodontal tissue destructionQ36703964
Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective moleculesQ36957089
The interface between obesity and periodontitis with emphasis on oxidative stress and inflammatory responseQ37389878
The Bi-Directional Relationship between Periodontal Disease and HyperlipidemiaQ37391359
Oral health risks of tobacco use and effects of cessationQ37723372
Association between overweight/obesity and periodontitis in adults. A systematic reviewQ37846793
Molecular inflammation as an underlying mechanism of the aging process and age-related diseasesQ37859163
Risk factors for periodontal disease.Q38097941
Modifiable risk factors in periodontitis: at the intersection of aging and diseaseQ38169796
Lipoxin A₄ inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expressionQ42009633
Association among menopause, hormone replacement therapy, and periodontal attachment loss in southern Brazilian women.Q43494844
Evaluation of antioxidant enzymes activity and malondialdehyde levels in patients with chronic periodontitis and diabetes mellitusQ44105103
Association between periodontitis and hyperlipidemia: cause or effect?Q45109352
Socioeconomic position and health: the differential effects of education versus income on the onset versus progression of health problemsQ47740701
Association of gingival crevicular fluid cortisol/dehydroepiandrosterone levels with periodontal statusQ47898175
White blood cell count in generalized aggressive periodontitis after non-surgical therapy.Q49144847
Association between neutrophil-lymphocyte ratio and mitral annular calcification.Q50478747
Serum plasminogen activator inhibitor-1 and tumor necrosis factor-α levels in obesity and periodontal disease.Q51364411
Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemiaQ51387165
Plasma lipid and blood glucose levels in patients with destructive periodontal disease.Q51554144
The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States.Q51886706
The association of serum lipids, lipoproteins, and apolipoproteins with coronary artery disease assessed by coronary arteriographyQ69850334
Metabolic diseases and their possible link to risk indicators of periodontitisQ74067549
PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITYQ76726210
PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTIONQ76844256
Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass graftingQ81514568
Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal diseaseQ81728805
P407language of work or nameEnglishQ1860
P921main subjectperiodontitisQ520127
lymphocyteQ715347
P1104number of pages9
P304page(s)2485-2493
P577publication date2015-08-23
P1433published inMedical Science MonitorQ15756323
P1476titleLipoxin A4 and Neutrophil/Lymphocyte Ratio: A Possible Indicator in Achieved Systemic Risk Factors for Periodontitis
P478volume21

Reverse relations

cites work (P2860)
Q50535391Association of Serum Triglyceride Level and Gemfibrozil Consumption With Periodontal Status.
Q98288074Biomarkers in biological fluids in adults with periodontitis and/or obesity: A meta-analysis
Q90205789Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic periodontitis before and after nonsurgical therapy
Q38899898Regulation of inflammation by lipid mediators in oral diseases
Q64094760The role of serum lipoxin A4 levels in the association between periodontal disease and metabolic syndrome

Search more.